White paper: The next step to automating clinical trials
Document
Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
However, there are new solutions that digitize manual processes, resulting in reduced site burden, timely kit level data for study teams, and ensuring safe delivery right to the patient.
What is on this page?
Click to jump to a specific section below.
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.
You may also be interested in
TSS Welcomes Gustaf Rasin as New Chief Operations Officer
TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
Read moreDownload Whitepaper
10 Steps to Navigating Sustainability in the Pharma Supply Chain
In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.
Read moreDownload Whitepaper
TSS Clinical Trials Digitalization User Forum 2021
We’re pleased to announce the first TSS Clinical Trials Digitalization User Forum on February 10-11, 2021
Read moreDownload WhitepaperYou may also be interested in
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
Extending TempMonitor BLE to Ultra-Low Temperatures
Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more